The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 901–1,000 of 1,644
Cai, R., Huang, R., Han, J., Sun, H., Sun, J. L., Xia, W., Tian, S., Dong, X., Shen, Y., & Wang, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12515-z · Cited by 27
Cognitive decline in older adults with epilepsy: The Cardiovascular Health Study
Choi, H., Thacker, E. L., Longstreth, W. T., Jr., Elkind, M. S. V., & Boehme, A. K. (2020) · Epilepsia · doi:10.1111/epi.16748 · Cited by 27
Association of cerebral microvascular dysfunction and white matter injury in Alzheimer’s disease
Bagi, Z. A., Kroenke, C. D., Fopiano, K. A., Tian, Y., Filosa, J. A., Sherman, L. S., Larson, E. B., Keene, C. D., Degener-O’Brien, K., Adeniyi, P. A., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00585-5 · Cited by 27
Burrage, E. N., Coblentz, T., Prabhu, S. S., Childers, R., Bryner, R. W., Lewis, S. E., DeVallance, E., Kelley, E. E., & Chantler, P. D. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231152551 · Cited by 28
Schneider, P., Büerger, K., Teipel, S. J., Uspenskaya, O., Hartmann, O., Hansson, O., Minthon, L., Rujescu, D., Moeller, H., Zetterberg, H., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.036 · Cited by 27
Dementia: When Is It Not Alzheimer Disease?
Kaplan, N. M., Palmer, B. F., & Vicioso, B. A. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200208000-00007 · Cited by 27
Vascular Risk Factors and Alzheimer's Disease
Stewart, R. J., Prince, M. J., & MANN, A. H. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00657.x · Cited by 26
Brain Microbleeds and Cognitive Function
Schneider, J. A. (2007) · Stroke · doi:10.1161/strokeaha.107.487173 · Cited by 27
Lynch, C., Eisenbaum, M., Algamal, M., Balbi, M., Ferguson, S., Mouzon, B., Saltiel, N. A., Ojo, J. O., Diaz-Arrastia, R. R., Mullan, M., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20954015 · Cited by 25
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
Prete, E. D., Beatino, M. F., Campese, N., Giampietri, L., Siciliano, G., Ceravolo, R., & Baldacci, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040221 · Cited by 29
Effects of Hypertension on Alzheimer’s Disease and Related Disorders
Malone, J. E., Elkasaby, M., & Lerner, A. J. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01221-5 · Cited by 26
Reekes, T. H., Ledbetter, C. R., Alexander, J., Stokes, K. Y., Pardue, S., Bhuiyan, M. A. N., Patterson, J. C., Lofton, K. T., Kevil, C. G., & Disbrow, E. A. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102633 · Cited by 26
Prajjwal, P., Marsool, M. D. M., Inban, P., Sharma, B., Asharaf, S., Aleti, S., Gadam, S., Sakini, A. S. A., & Hadi, D. D. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101557 · Cited by 30
A nonstationary Markov transition model for computing the relative risk of dementia before death
Yu, L., Griffith, W. S., Tyas, S. L., Snowdon, D. A., & Kryscio, R. J. (2010) · Statistics in Medicine · doi:10.1002/sim.3828 · Cited by 26
Self-citationAutonomous orientation predicts longevity: New findings from the Nun Study
Weinstein, N., Legate, N., Ryan, W. S., & Hemmy, L. S. (2018) · Journal of Personality · doi:10.1111/jopy.12379 · Cited by 28
Komatsu, S., Takahashi, S., Yutani, C., Ohara, T., Takewa, M., Hirayama, A., & Kodama, K. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.12.004 · Cited by 26
Update on Alzheimer Drugs (Galantamine)
Raskind, M. A. (2003) · The Neurologist · doi:10.1097/01.nrl.0000087722.46430.c4 · Cited by 26
Age and apoE associations with complex pathologic features in Alzheimer's disease
Jicha, G. A., Parisi, J. E., Dickson, D. W., Cha, R. H., Johnson, K., Smith, G. E., Boeve, B. F., Petersen, R. C., & Knopman, D. S. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.008 · Cited by 26
Use of Antidementia Agents in Vascular Dementia: Beyond Alzheimer Disease
Farlow, M. R. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.10.1350 · Cited by 26
Mixed Dementia: Alzheimer’s Cerebrovascular Disease
Rockwood, K. J. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203008949 · Cited by 26
ALZHEIMER'S DISEASE AND VASCULAR FACTORS: FACTS AND THEORIES
Pansari, K., Gupta, A., & Thomas, P. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11233.x · Cited by 27
Treating the full spectrum of dementia with memantine
Winblad, B. G., & Jelić, V. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.937 · Cited by 26
Derby, C. A. (2020) · Current Epidemiology Reports · doi:10.1007/s40471-020-00231-8 · Cited by 27
Ingala, S., Mazzai, L., Sudre, C. H., Salvadó, G., Brugulat-Serrat, A., Wottschel, V., Falcon, C., Operto, G., Tijms, B., Gispert, J. D., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.015 · Cited by 25
Hosoki, S., Tanaka, T., & Ihara, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105015 · Cited by 25
Cummings, J. L., Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210570 · Cited by 25
Depression, Strokes and Dementia: New Biological Insights into an Unfortunate Pathway
Hakim, A. M. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/649629 · Cited by 26
Makino, T., Umegaki, H., Suzuki, Y., Yanagawa, M., Nonogaki, Z., Nakashima, H., & Kuzuya, M. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12176 · Cited by 25
Vascular risk factors and progression in Alzheimer's disease
Sakurai, H., Hanyu, H., Sato, T., Kanetaka, H., Shimizu, S., Hirao, K., Kikukawa, M., & Iwamoto, T. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00669.x · Cited by 25
Hertze, J., Palmqvist, S., Minthon, L., & Hansson, O. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000348353 · Cited by 24
Ishikawa, H., Meguro, K., Ishii, H., Tanaka, N., & Yamaguchi, S. (2010) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.08.008 · Cited by 25
Li, G., Zou, L., Jack, C. R., Yang, Y., & Yang, E. S. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.005 · Cited by 25
Current Concepts in Vascular Cognitive Impairment and Pharmacotherapeutic Implications
Rojas‐Fernandez, C. H., & Moorhouse, P. A. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l703 · Cited by 25
Donepezil Treatment of Vascular Dementia
Meyer, J. S., Chowdhury, M. H., Xu, G., Li, Y., & Quach, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04854.x · Cited by 25
Differential Diagnosis and Early Detection of Dementia
Small, G. W. (1998) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199821001-00004 · Cited by 26
Are vascular factors involved in Alzheimer’s disease? Facts and theories
Iorio, A. D., Zito, M., Lupinetti, M. C., & Abate, G. (1999) · Aging Clinical and Experimental Research · doi:10.1007/bf03339811 · Cited by 25
Fatima, G., Ashiquzzaman, A., Kim, S. S., Kim, Y. R., Kwon, H.-S., & Chung, E. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106877 · Cited by 26
Whitehead, S. N., Massoni, E., Cheng, G., Hachinski, V., Cimino, M., Balduini, W., & Cechetto, D. F. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.008 · Cited by 24
Suwa, M., Yamaguchi, S., Komori, T., Kajimoto, S., & Kino, M. (2015) · BioMed Research International · doi:10.1155/2015/153437 · Cited by 25
Pre-dementia Memory Impairment is Associated with White Matter Tract Affection
Grambaitė, R., Reinvang, I., Selnes, P., Fjell, A. M., Walhovd, K. B., Stenset, V. T. V., & Fladby, T. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001360 · Cited by 24
Ramos‐Miguel, A., Garcı́a-Sevilla, J. A., Barr, A. M., Bayer, T. A., Falkai, P., Leurgans, S. E., Schneider, J. A., Bennett, D. A., Honer, W. G., & García-Fuster, M. J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0168-x · Cited by 23
Pan, M.-L., Hsu, C., Chen, Y.-M., Yu, H.-K., & Hu, G. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.06.036 · Cited by 24
Furtner, J., & Prayer, D. (2021) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-021-00825-x · Cited by 24
Bilingualism as a Contributor to Cognitive Reserve: What it Can do and What it Cannot do
Berkes, M., & Bialystok, E. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221091417 · Cited by 26
Förster, C. Y., Shityakov, S., Scheper, V., & Lenarz, T. (2022) · Biomolecules · doi:10.3390/biom12111717 · Cited by 30
Post-Stroke Cognitive Impairments
Васильевна, В. Н., Nikitina, L. Y., Parfenov, V. A., & Yakhno, N. N. (2009) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-009-9198-3 · Cited by 24
Alzheimer disease is in part a thrombohemorrhagic disorder
Schmaier, A. H. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13277 · Cited by 24
Dugger, B. N., Malek‐Ahmadi, M. H., Monsell, S. E., Kukull, W. A., Woodruff, B. K., Reiman, E. M., Beach, T. G., & Wilson, J. R. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000138 · Cited by 24
Atwi, S., Metcalfe, A. W. S., Robertson, A. D., Rezmovitz, J., Anderson, N. D., & MacIntosh, B. J. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00748 · Cited by 26
Secondary Stroke Prevention Strategies for the Oldest Patients
Bushnell, C., & Colon-Emeric, C. S. (2009) · Drugs & Aging · doi:10.2165/00002512-200926030-00003 · Cited by 25
Roche, R. A. P., Mullally, S. L., McNulty, J. P., Hayden, J., Brennan, P., Doherty, C. P., Fitzsimons, M. B., McMackin, D., Prendergast, J., Sukumaran, S., et al. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-136 · Cited by 25
Neurocognitive disorder in hypertensive patients. Heart–Brain Study
Vicario, A., Cerezo, G. H., Sueldo, M. D., Zilberman, J. M., Pawluk, S. M., Lódolo, N., Cerchio, A. E. D., Ruffa, R. M., Plunkett, R., Giuliano, M. E., et al. (2018) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2018.01.004 · Cited by 24
Tan, K. P., Ang, J. K., Koh, E. B. Y., Pang, N. T. P., & Mat Saher, Z. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054232 · Cited by 23
A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model
Pluta, R. M. (2024) · Current Alzheimer Research · doi:10.2174/0115672050320921240627050736 · Cited by 24
Vascular dementia: World Stroke Organization fact sheet 2026
Cai, Y., Mok, V., & Markus, H. S. (2026) · International Journal of Stroke · doi:10.1177/17474930251404243 · Cited by 23
Xiang, J. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4661 · Cited by 23
Connecting vascular aging and frailty in Alzheimer’s disease
Sabbatinelli, J., Ramini, D., Giuliani, A., Recchioni, R., Spazzafumo, L., & Olivieri, F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111444 · Cited by 23
Genetic variation of oxidative phosphorylation genes in stroke and Alzheimer's disease
Biffi, A., Sabuncu, M. R., Desikan, R. S., Schmansky, N., Salat, D. H., Rosand, J. M., & Anderson, C. D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.141 · Cited by 23
Preventing dementia: role of vascular risk factors and cerebral emboli
Purandare, N. B. (2009) · British Medical Bulletin · doi:10.1093/bmb/ldp020 · Cited by 24
Bressler, J., Mosley, T. H., Penman, A. D., Gottesman, R. F., Windham, B. G., Knopman, D. S., Wruck, L. M., & Boerwinkle, E. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32509 · Cited by 24
Raman, M. R., Kantarci, K., Murray, M. E., Jack, C. R., & Vemuri, P. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.006 · Cited by 23
Amtul, Z., Hill, D. J., Arany, E. J., & Cechetto, D. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-22985-4 · Cited by 23
López, O. L., Mackell, J. A., Sun, Y., Kassalow, L. M., Xu, Y., McRae, T. D., & Li, H. (2008) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)31515-7 · Cited by 23
Targeting Cell Death in Dementia
Francis, P. T. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213803.82058.46 · Cited by 22
Multiple brain pathologies in dementia are common
Woodward, M., Mackenzie, I. R., Hsiung, G. R., Jacova, C., & Feldman, H. (2010) · European Geriatric Medicine · doi:10.1016/j.eurger.2010.07.012 · Cited by 23
Benavente, O., White, C. L., & Roldan, A. (2005) · Current Cardiology Reports · doi:10.1007/s11886-005-0006-6 · Cited by 23
PP2A Ligand ITH12246 Protects against Memory Impairment and Focal Cerebral Ischemia in Mice
Lorrio, S., Romero, A., González‐Lafuente, L., Lajarín-Cuesta, R., Martínez-Sanz, F. J., Estrada, M., Samadi, A., Marco, J. L., Rodrı́guez-Franco, M. I., Villarroya, M., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400050p · Cited by 23
Vascular Changes in Iowa‐Type Hereditary Cerebral Amyloid Angiopathy
Shin, Y., Cho, H. S., Rebeck, G. W., & Greenberg, S. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04822.x · Cited by 24
Coello, C. S., Willoch, F., Selnes, P., Gjerstad, L., Fladby, T., & Skretting, A. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.01.043 · Cited by 23
Cerebral amyloid angiopathy and dementia
Greenberg, S. M. (2002) · Neurology · doi:10.1212/wnl.58.11.1587 · Cited by 23
The Nun Study: Insights from 30 years of aging and dementia research
Clarke, K. M., Etemadmoghadam, S., Danner, B., Corbett, C., Ghaseminejad‐Bandpey, A., Dopler, M. B., Parker‐Garza, J., Alhneif, M., Babu, S., Ogunbona, O. B., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14626 · Cited by 24
Brand, C., Alber, B., Fladung, A.-K., Knauer, K., König, R., Oechsner, A., Schneider, I. L., Tumani, H., Widder, B., Wirtz, C. R., et al. (2013) · British Journal of Neurosurgery · doi:10.3109/02688697.2013.815314 · Cited by 22
den Heijer, T., van der Lijn, F., Ikram, M. A., Koudstaal, P. J., van der Lugt, A., Krestin, G. P., Vrooman, H. A., Albert Hofman, D., Niessen, W. J., & Breteler, M. M. B. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.07.005 · Cited by 22
Historical Influences on Aging and Behavior
Schaie, K. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380882-0.00003-6 · Cited by 25
Davis, C. M., Bah, T. M., Zhang, W. H., Nelson, J. W., Golgotiu, K., Nie, X. J., Alkayed, F. N., Young, J. M., Woltjer, R. L., Silbert, L. C., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12214 · Cited by 21
Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS‐HD study
Jiang, X., O’Bryant, S. E., Johnson, L. A., Rissman, R. A., Yaffe, K. S., & The Health and Aging Brain Study (HABS‐HD) Study Team (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12394 · Cited by 21
Gidyk, D. C., Deibel, S. H., Hong, N. S., & McDonald, R. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00245 · Cited by 22
Alladi, S., Kaul, S., Meena, A. K., Somayajula, S., Umadevi, M., & Reddy, J. M. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2004.09.004 · Cited by 22
Yanuck, D., Mihos, C. G., & Santana, O. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.704455 · Cited by 21
Monkey-based Research on Human Disease: The Implications of Genetic Differences
Bailey, J. (2014) · Alternatives to Laboratory Animals · doi:10.1177/026119291404200504 · Cited by 22
Pillai, J. A., Butler, R. S., Bonner‐Jackson, A., & Leverenz, J. B. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000448243 · Cited by 22
Blood Pressure Control and Protection of the Aging Brain
Wahidi, N., & Lerner, A. J. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00747-y · Cited by 24
Xiong, Y., Wong, A., Mok, V., Tang, W. K., Lam, W. W. M., Kwok, T. C. Y., Chu, C. W., Chan, A. Y. Y., & Wong, K. S. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2652 · Cited by 22
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease
Connelly, P., Prentice, N. P., & Fowler, K. G. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1331 · Cited by 22
Libon, D. J., Price, C. C., Heilman, K. M., & Grossman, M. (2006) · Cognitive and Behavioral Neurology · doi:10.1097/01.wnn.0000209870.69522.a3 · Cited by 22
Dementia in Rural Primary Care Practices in Lake County, Oregon
Camicioli, R. M., Willert, P., Lear, J., Grossmann, S., Kaye, J. A., & Butterfield, P. (2000) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870001300207 · Cited by 22
Alzheimer's disease: Its diagnosis and pathogenesis
Kril, J. J., & Halliday, G. M. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)48016-0 · Cited by 22
Insulin and Alzheimer’s disease
Galasko, D. (2003) · Neurology · doi:10.1212/wnl.60.12.1886 · Cited by 22
Ojo, J. O., Reed, J. M., Crynen, G. C., Vallabhaneni, P., Evans, J., Shackleton, B., Eisenbaum, M., Ringland, C., Edsell, A., MULLAN, M. J., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.658605 · Cited by 22
Chun, M. Y., Jang, H., Kim, S.-J., Park, Y. H., Yun, J., Lockhart, S. N., Weiner, M. W., DeCarli, C. S., Moon, S. H., Choi, J. Y., et al. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-331603 · Cited by 20
Soluble Biomarkers of Cerebrovascular Pathologies
Foley, K. E., & Wilcock, D. M. (2024) · Stroke · doi:10.1161/strokeaha.123.044172 · Cited by 24
Choi, S. H., Kim, S., Han, S.-H., Na, D. L., Kim, D. K., Cheong, H., Lee, J., Kim, S. Y., Hong, C. H., Moon, S. Y., et al. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0845-4 · Cited by 21
Yamamoto, N., Arima, H., Sugiura, T., Hirate, H., Taniura, H., Suzuki, K., & Sobue, K. (2013) · Anesthesiology · doi:10.1097/aln.0b013e31828afc16 · Cited by 21
Katzav, A., Faust‐Socher, A., Kvapil, F., Michaelson, D. M., Blank, M., Pick, C. G., Shoenfeld, Y., Korczyn, A. D., & Chapman, J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.007 · Cited by 21
Zhao, Q., Yokozawa, T., Tsuneyama, K., Tanaka, K., Miyata, T., Shibahara, N., & Matsumoto, K. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-33 · Cited by 21
Kidney Function and the Risk of Stroke and Dementia: The Rotterdam Study
Koop‐Nieuwelink, C., Sedaghat, S., Mutlu, Ü., Licher, S., Franco, O. H., Ikram, M. A., Geerlings, M. I., Ikram, M. K., & Bos, D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181086 · Cited by 21
Halling, A., & Berglund, J. S. (2006) · European Journal of General Practice · doi:10.1080/13814780600881128 · Cited by 21
Hypoxia Enhances β-Amyloid-Induced Apoptosis in Rat Cultured Hippocampal Neurons
Egashira, N., Iwasaki, K., Ishibashi, M., Hatip-Al-Khatib, I., Wolozin, B. L., Mishima, K., Irie, K., & Fujiwara, M. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.90.321 · Cited by 21
The pattern of cognitive symptoms predicts time to dementia onset
Sacuiu, S. F., Gustafson, D., Johansson, B. E. A., Thorvaldsson, V., Berg, S., Sjögren, M. J. C., Guo, X., Östling, S., & Skoog, I. G. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.10.007 · Cited by 21
Craig, L. A., Hong, N. S., Kopp, J., & McDonald, R. J. (2008) · Experimental Brain Research · doi:10.1007/s00221-008-1592-5 · Cited by 21
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
